Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Account Payables: 2017-2021

Historic Change in Account Payables for Cogent Biosciences (COGT) over the last 5 years, with Dec 2021 value amounting to -$866,000.

  • Cogent Biosciences' Change in Account Payables fell 1031.18% to -$866,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.8 million, marking a year-over-year increase of 212.24%. This contributed to the annual value of $1.4 million for FY2024, which is 71.78% down from last year.
  • Cogent Biosciences' Change in Account Payables amounted to -$866,000 in Q4 2021, which was down 136.74% from $2.4 million recorded in Q3 2021.
  • Over the past 5 years, Cogent Biosciences' Change in Account Payables peaked at $2.4 million during Q3 2021, and registered a low of -$2.6 million during Q1 2020.
  • Moreover, its 3-year median value for Change in Account Payables was $5,500 (2020), whereas its average is $163,667.
  • Examining YoY changes over the last 5 years, Cogent Biosciences' Change in Account Payables showed a top increase of 41,825.00% in 2021 and a maximum decrease of 1,031.18% in 2021.
  • Over the past 5 years, Cogent Biosciences' Change in Account Payables (Quarterly) stood at -$774,000 in 2017, then soared by 192.51% to $716,000 in 2018, then skyrocketed by 121.93% to $1.6 million in 2019, then tumbled by 94.15% to $93,000 in 2020, then slumped by 1,031.18% to -$866,000 in 2021.
  • Its Change in Account Payables stands at -$866,000 for Q4 2021, versus $2.4 million for Q3 2021 and $1.7 million for Q2 2021.